Abstract
Primary renal synovial sarcoma is a rare tumor having a specific chromosomal translocation t(X; 18) (p11.2; q11.2). The clinical features of this tumor and radiologic appearances are quite similar to those of renal cell carcinoma. Confirmatory diagnosis requires fluorescent in situ hybridization or reverse transcriptase polymerase chain reaction validation for differentiating the tumors from sarcomatoid renal cell carcinoma. We present a case of primary renal synovial sarcoma that was diagnosed in a middle-aged man.
Keywords: Renal synovial sarcoma, Fluorescent in-situ hybridisation, Reverse transcriptase - Polymerised chain reaction
Introduction
Synovial Sarcoma is the fourth most common type of soft tissue sarcoma primarily affecting the extremities in young adults.1 However, primary renal synovial sarcomas very rarely occur in the kidney, with only <50 cases reported in literature.2 We present a case of primary renal synovial sarcoma in a middle-aged man treated by us.
Case presentation
A 46-year-old man, known to be diabetic and on oral hypoglycemic agents since the last 5 years, presented to us with dull aching left flank pain of few weeks duration. Clinically, there was a palpable lump in the left hypochondrium and lumbar region. His renal function test reports were normal. Ultrasonography scan of the abdomen showed mixed echoic left renal mass of size 12 × 11 cm suspicious of renal cell carcinoma. Computed tomography scan of the abdomen showed a heterogeneously enhancing mass lesion of size 12.8 × 11.7 cm (Fig. 1). The patient underwent left radical nephrectomy.
Figure 1.
Computed tomographic appearance of the renal tumor.
Histopathology (Fig. 2) revealed renal tissue to be infiltrated by a tumor composed of monomorphic spindle shaped cells with indistinct cell borders and scant cytoplasm. Cells were arranged in short intersecting fascicles and sheets. Tumor showed high mitotic activity with cystic structures lined by polygonal epithelial cells with hobnailing of nuclei and occasional mitotic figures in the lining epithelial cells.
Figure 2.

Histopathology of the renal tumor.
On immunohistochemistry analysis, the glandular component showed positive reactivity for pancytokeratin and epithelial membrane antigen, whereas the spindle cell component was reactive for Bcl2. Tumor cells were nonreactive for CD34. This overall profile was suggestive of synovial sarcoma.
To confirm the diagnosis of synovial sarcoma, FISH (fluorescent in situ hybridisation) and RT-PCR (reverse transcriptase polymerase chain reaction) were done. FISH was positive for SYT (18q11.2) rearrangement (Fig. 3) and RT-PCR was positive for SYT-SSX2 translocation.
Figure 3.

Fluorescent in situ hybridization of the renal tumor.
Discussion
Primary renal synovial sarcoma was first described in 1999 by Faria et al.3 Histologically, renal synovial sarcoma is classified as biphasic synovial sarcoma, monophasic spindle synovial sarcoma, and monophasic epithelial synovial sarcoma.
It is difficult to differentiate this tumor from sarcomatiod renal cell carcinoma, adult Wilm tumor, and congenital mesoblastic nephroma because of histologic similarities and nonspecific immunohistochemistry markers.4 Metastatic sarcoma and invasion from retroperitoneal sarcoma also should be ruled out.5, 6 This entity lacks any specific imaging or clinical findings. However, t(X; 18) (p11.2; q11.2) translocation is characteristic of synovial sarcoma, and methods to detect this translocation include cytogenetic analysis, RT-PCR, and FISH.7 Three types of fusion defects, mainly SYT-SSX1, SYT-SSX2, and rarely SYT-SSX4 are demonstrated by renal synovial sarcoma.8 These findings were also observed in the tumor studied in our patient.
Surgical resection is the mainstay, although surgery alone has poor prognosis. Reports of sensitivity of this tumor to ifosfamide- and doxorubicin-based chemotherapy do exist,9 but no clear guidelines are available regarding adequate treatment of this rare entity.
Conclusion
Primary Renal Synovial Sarcoma is a very rare tumour and correct diagnosis requires specific pathological tests.
Footnotes
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
References
- 1.Kim D.H., Sohn J.H., Lee M.C. Primary synovial sarcoma of the kidney. Am J Surg Pathol. 2000;24:1097–1104. doi: 10.1097/00000478-200008000-00007. (PubMed) [DOI] [PubMed] [Google Scholar]
- 2.Takeshi N., Teruo I., Hiroshi U. Monophasic primary renal synovial sarcoma accompanied with a hemorrhagic cyst. Urol J. 2011;8:244–247. [PubMed] [Google Scholar]
- 3.Faria P., Argani P., Epstein J. Primary synovial sarcoma of the kidney: A molecular subset of so called embryonal renal sarcoma. Mod Pathol Am. 1999;12:94. [Google Scholar]
- 4.Shao L., Hill D.A., Perlman E.J. Expression of WT-1, Bcl2 and CD34 by primary renal spindle cell tumors in children. Pediatr Dev Pathol. 2004;7:577–582. doi: 10.1007/s10024-004-4037-6. [DOI] [PubMed] [Google Scholar]
- 5.Mauricio A., Palau L., Pham T.T. Primary synovial sarcoma of the kidney with rhabdoid features. Int J Surg Pathol. 2007;15:421–428. doi: 10.1177/1066896907302421. (PubMed) [DOI] [PubMed] [Google Scholar]
- 6.Divetia M., Karpate A., Basak R., Desai S.B. Synovial sarcoma of the kidney. Ann Diagn Pathol. 2008;12:333–339. doi: 10.1016/j.anndiagpath.2008.02.011. (PubMed) [DOI] [PubMed] [Google Scholar]
- 7.Argani P., Faria P.A., Epstein J.I. Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney. Am J Surg Pathol. 2000;24:1087–1096. doi: 10.1097/00000478-200008000-00006. [DOI] [PubMed] [Google Scholar]
- 8.Tornkvist M., Wejde J., Ahlen J. A novel case of synovial sarcoma of the kidney: impact of SS18/SSX analysis of renal hemangiopericytoma like tumors. Diagn Mo Lpathol. 2004;13:47–51. doi: 10.1097/00019606-200403000-00008. [DOI] [PubMed] [Google Scholar]
- 9.Park S.J., Kim H.K., Kim C.K. A case of renal synovial sarcoma: complete remission was induced by chemotherapy with doxorubicin and ifosfamide. Korean J Intern Med. 2004;19:62–65. doi: 10.3904/kjim.2004.19.1.62. [DOI] [PMC free article] [PubMed] [Google Scholar]

